Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NO MALIGNANCY”

554 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 554 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02785952
What this trial is testing

Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Who this might be right for
Recurrent Squamous Cell Lung CarcinomaStage IV Squamous Cell Lung Carcinoma AJCC v7
SWOG Cancer Research Network 275
Not applicableNot Yet RecruitingNCT07370571
What this trial is testing

NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE)

Who this might be right for
Breast Cancer
Clinica Universidad de Navarra, Universidad de Navarra 827
Not applicableStudy completedNCT02778308
What this trial is testing

Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma

Who this might be right for
Gallbladder Cancer
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research 100
Not applicableStudy completedNCT03402568
What this trial is testing

Alcohol Consumption and Circulating Metabolites

Who this might be right for
No Condition, Focus: Metabolites of Alcohol Consumption
International Agency for Research on Cancer 2,974
Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Not applicableUnknownNCT00360750
What this trial is testing

Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye

Who this might be right for
Retinoblastoma
Children's Cancer and Leukaemia Group
Large-scale testing (Phase 3)UnknownNCT00003924
What this trial is testing

Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Study Association 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238624
What this trial is testing

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerBRAF Gene Mutation+1 more
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT06772623
What this trial is testing

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Who this might be right for
Non Small Cell Lung Carcinoma
AbbVie 252
Not applicableNo Longer AvailableNCT01260779
What this trial is testing

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Who this might be right for
Cutaneous or Subcutaneous Tumors Where There is no Comparable or SatisfactoryApproved Alternative Therapy
Provectus Biopharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT00816400
What this trial is testing

A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.

Who this might be right for
Cancer
MedImmune LLC 49
Testing effectiveness (Phase 2)Study completedNCT02403531
What this trial is testing

Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Neoplasms
Mian XI 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Large-scale testing (Phase 3)Study completedNCT00427713
What this trial is testing

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Research UK 800
Not applicableUnknownNCT00850798
What this trial is testing

The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Taipei Veterans General Hospital, Taiwan 208
Early research (Phase 1)Study completedNCT02162888
What this trial is testing

A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients

Who this might be right for
Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate
Eagle Pharmaceuticals, Inc. 81
Large-scale testing (Phase 3)UnknownNCT03664895
What this trial is testing

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 224
Testing effectiveness (Phase 2)Study completedNCT03159845
What this trial is testing

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Stem Cell Transplant Complications
Azienda Ospedaliero, Universitaria Pisana 20
Testing effectiveness (Phase 2)Temporarily pausedNCT05642195
What this trial is testing

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNon-Small Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung+1 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT00896636
What this trial is testing

Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration

Who this might be right for
Breast CancerHealthy, no Evidence of Disease
Northwestern University 385
Load More Results